NAFLD's pathophysiology is complex, involving intricate interactions between lipid metabolism, insulin resistance, inflammation, oxidative stress, and gut microbiome imbalance (Manne et al. 2018). This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.